Lukas Biomedical (ROCO:6814) Pretax Margin % : -12.87% (As of Jun. 2023)

Lukas Biomedical Pretax Margin % Chart

Lukas Biomedical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Pretax Margin %	Get a 7-Day Free Trial					-30.25	-30.44	-30.65	-23.77	-12.87

Competitive Comparison of Lukas Biomedical's Pretax Margin %

For the Biotechnology subindustry, Lukas Biomedical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lukas Biomedical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lukas Biomedical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Lukas Biomedical's Pretax Margin % falls into.

Lukas Biomedical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Lukas Biomedical's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Lukas Biomedical's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lukas Biomedical  (ROCO:6814) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Lukas Biomedical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Lukas Biomedical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lukas Biomedical (ROCO:6814) Business Description